Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 9, 2026 · Leadership change · Investor press release · Financial statements
Quanterix Corp
8
Leadership change
Jun 9, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
Quanterix Corp filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
1 Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer BILLERICA, Mass. —June 9, 2026-- Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Quanterix Corp reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
